200630-46-2
Chemical Structure
3-O-Methyldopa monohydrate
Synonym(s): 3-Methoxy-L-tyrosine monohydrate; 3-O-Methyl-L-DOPA monohydrate
- CAS. Nr.: 200630-46-2
- Formula:C10H15NO5
- Molecular Weight:229.23
IUPAC Name: (S)-2-amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid hydrate
InChIKey: IDRRCKUGGXLORG-FJXQXJEOSA-N
SMILES: O=C([C@H](CC1=CC=C(C(OC)=C1)O)N)O.O
Biological Activity: 3-O-Methyldopa monohydrate (3-Methoxy-L-tyrosine monohydrate) is a significant metabolite of L-DOPA produced through the action of catechol O-methyltransferase (COMT). Unlike its precursor, 3-O-Methyldopa does not serve as a substrate or inhibitor of L-amino acid decarboxylase activity. Additionally, the inhibition of COMT can amplify the anti-Parkinson effects of L-DOPA.
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3-O-Methyldopa monohydrate | 98.87% | 3-O-Methyldopa monohydrate (3-Methoxy-L-tyrosine monohydrate) is a significant metabolite of L-DOPA produced through the action of catechol O-methyltransferase (COMT). Unlike its precursor, 3-O-Methyldopa does not serve as a substrate or inhibitor of L-amino acid decarboxylase activity. Additionally, the inhibition of COMT can amplify the anti-Parkinson effects of L-DOPA. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
